Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check14 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe study page now displays a 403 Forbidden error rather than the detailed study record. The view shows a minimal header/footer, indicating restricted access to the page.SummaryDifference18%

- Check56 days agoChange DetectedThe page now shows a new revision tag v3.6.6, replacing the previous v3.6.5. This reflects a maintenance update to the page.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision updated to v3.6.5, indicating a small system update.SummaryDifference0.0%

- Check92 days agoChange DetectedThe revision label on the page was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new build. This change does not modify visible content or functionality for users on the study details page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.